ob-gyn - high risk pregnancy


Testing Pregnant Women who are High Risk for Drug Abuse

Pregnant women with a history of illicit drug or controlled prescription medication use, along with women having psychiatric diagnoses, are found to be at high risk for drug abuse during pregnancy. Maternal drug use during pregnancy can have profoundly adverse developmental effects on the fetus; including neurological development, physical development and stillbirths.

Proper treatment and management can be established for women who are pregnant and abusing drugs once the drugs of abuse are been identified.

Discovering prescription or illicit drug abuse early in a pregnancy is critical to managing the overall wellbeing of the fetus.

Neonatal Abstinence Syndrome

Babies who are exposed to opioids, methadone, buprenorphine or heroin in utero are at risk for being born with Neonatal Abstinence Syndrome (NAS). Complications for a newborn associated with NAS includes, premature birth, low birth weight, seizures, respiratory diagnoses, and feeding difficulties. Mean hospital charges for a newborn diagnosed with NAS can range from $60,000 to over $90,000 dependent upon the course of treatment; while the average cost for uncomplicated term infants is $3,500. Incidence and prevalence of NAS has increased rapidly over the past decade.

Detecting Drug Use During Pregnancy Protects the Fetus, Mother, and Provider

American College of Obstetrics and Gynecologists (ACOG) recommends universal screening for all maternal substance use.

  • Screening could be maternal self-report or drug testing
  • Provide brief intervention and referral to treatment in order to provide benefit and do no harm

Why screen for drug use during pregnancy?

  • Protect fetus/newborn
  • Encourage mother to obtain treatment
  • Protect provider
  • Reduce healthcare cost

Outcomes associated with drug use during pregnancy

  • Miscarriage
  • Premature birth
  • Fetal demise
  • Birth defects
  • Developmental delays
  • Physical and psychological disorders

Alcohol and Tobacco still pose greatest risks to fetus

ACOG recommends increased focus on curbing alcohol and tobacco use during pregnancy

  • Curbing use of alcohol and tobacco before and during pregnancy yields greatest public health gains for maternal and child welfare.
  • Alcohol and cigarettes cause long-term serious health consequences for mothers and infants, including prematurity. Smoking is the #1 risk factor for delivering a baby prematurely.
  • Polysubstance use is common among women who use drugs. Those who misuse prescription medications or illicit drugs also tend to smoke and use alcohol.

The LabSource Difference...

High Sensitivity Definitive Toxicology Testing

STAT Accounts Receive Expedited High Sensitivity Definitive Toxicology Testing Results.

30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.

High Sensitivity Enzymatic Specimen Incubation Converts All Drugs and Metabolites to a Free-Detectable Form.

Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.

Proprietary Software Verifies Accuracy of All Detected Drugs with Results Reviewed by Two Certifying Scientists.

Patient Results are Compared to the Patient’s Previous Results.

Multi-Level Verification Process for Positive Non-Prescribed Medications.

Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.

contact us

Ask About Our Clinical Toxicology Testing Services

   call now   LabSource Phone   (877) 930-3390